Christian Torp-Pedersen: Clinical Trials

1 unknown. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Unknown 1

Follow Christian Torp-Pedersen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Rivaroxaban or Aspirin for Biological Aortic Prosthesis Rivaroxaban 10 MG, Aspirin - Aortic Stenosis, Aortic Regurgitation	Phase 4	Unknown	Christian Torp-Pedersen	1000	2017-01-01	2018-06-27

Conditions studied

Aortic Valve Insufficiency (1)  ·  Aortic Valve Stenosis (1)  ·  Thrombosis (1)

Interventions

Aspirin (1)  ·  Rivaroxaban (1)

Countries

Denmark (1)

NIH funding

2016 (1)